Beranda › Penyakit Pencernaan › Michigan
Uji klinis Penyakit Pencernaan di Michigan
6 studi untuk Penyakit Pencernaan mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- University of Michigan Health, Ann Arbor
- Henry Ford, Detroit
Menerima peserta
Usia 65 hingga 82 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05612347A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- The Cancer & Hematology Centers, Big Rapids
- The Cancer & Hematology Centers, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800Product Surveillance Registry
- Ann Arbor
- Bay City
- Lansing
- dan 2 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT01524276A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chesterfield
- 89bio Clinical Study Site, Wyoming
- 89bio Clinical Study Site, Ypsilanti
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Ann Arbor
- 89bio Clinical Study Site, Clinton Township
- 89bio Clinical Study Site, Detroit
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06419374Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.